BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 30678118)

  • 1. Growth Hormone (GH) Therapy During the Transition Period: Should We Think About Early Retesting in Patients with Idiopathic and Isolated GH Deficiency?
    Penta L; Cofini M; Lucchetti L; Zenzeri L; Leonardi A; Lanciotti L; Galeazzi D; Verrotti A; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30678118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is retesting in growth hormone deficient children really useful?
    Meazza C; Gertosio C; Pagani S; Pilotta A; Tinelli C; Buzi F; Farello G; Genoni G; Bona G; Bozzola M
    Minerva Endocrinol; 2017 Dec; 42(4):325-330. PubMed ID: 27304071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of arginine plus growth hormone releasing hormone to evaluate growth hormone (GH) secretory status in children with GH deficiency.
    Keller A; Donaubauer J; Kratzsch J; Pfaeffle R; Hirsch W; Kiess W; Keller E
    J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1307-14. PubMed ID: 18341090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early retesting by GHRH + arginine test shows normal GH response in most children with idiopathic GH deficiency.
    Bizzarri C; Pedicelli S; Boscherini B; Bedogni G; Cappa M; Cianfarani S
    J Endocrinol Invest; 2015 Apr; 38(4):429-36. PubMed ID: 25376365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of the optimal growth hormone cut-off level in insulin tolerance testing for growth hormone secretion in patients with childhood-onset growth hormone deficiency during transition to adulthood.
    Bonfig W; Bechtold S; Bachmann S; Putzker S; Fuchs O; Pagel P; Schwarz HP
    J Pediatr Endocrinol Metab; 2008 Nov; 21(11):1049-56. PubMed ID: 19189699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment: Retesting early in the course of GH treatment.
    Vuralli D; Gonc EN; Ozon ZA; Alikasifoglu A; Kandemir N
    Growth Horm IGF Res; 2017 Jun; 34():31-37. PubMed ID: 28511077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
    Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) secretion in patients with childhood-onset GH deficiency: retesting after one year of therapy and at final height.
    Thomas M; Massa G; Maes M; Beckers D; Craen M; François I; Heinrichs C; Bourguignon JP;
    Horm Res; 2003; 59(1):7-15. PubMed ID: 12566729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
    Maghnie M; Strigazzi C; Tinelli C; Autelli M; Cisternino M; Loche S; Severi F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of permanent growth hormone deficiency (GHD) in young adults with childhood onset GHD: a multicenter study.
    Berberoğlu M; Sıklar Z; Darendeliler F; Poyrazoğlu S; Darcan S; Işgüven P; Bideci A; Ocal G; Bundak R; Yüksel B; Arslanoğlu I
    J Clin Res Pediatr Endocrinol; 2008; 1(1):30-7. PubMed ID: 21318062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluation of growth hormone deficiency during and after growth hormone (GH) treatment: diagnostic value of GH tests and IGF-I and IGFBP-3 measurements.
    Darendeliler F; Spinu I; Bas F; Bundak R; Isgüven P; Arslanoğlu I; Saka N; Sükür M; Günöz H
    J Pediatr Endocrinol Metab; 2004 Jul; 17(7):1007-12. PubMed ID: 15301049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of growth hormone response to GHRH plus arginine test in children with idiopathic short stature: role of peak time.
    Castagno M; Monzani A; Zanetta S; Genoni G; Giglione E; Ricotti R; Bona G; Prodam F; Bellone S
    J Endocrinol Invest; 2018 Aug; 41(8):977-983. PubMed ID: 29423542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.